Orgenesis Revenue and Competitors
Estimated Revenue & Valuation
- Orgenesis's estimated annual revenue is currently $15.2M per year.
- Orgenesis's estimated revenue per employee is $183,012
- Orgenesis's total funding is $29.3M.
Employee Data
- Orgenesis has 83 Employees.
- Orgenesis grew their employee count by 19% last year.
Orgenesis's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CFO, Orgenesis LTD | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | COO | Reveal Email/Phone |
4 | SVP Quality Strategy | Reveal Email/Phone |
5 | Head Global Operation - Supply | Reveal Email/Phone |
6 | Therapy Officer | Reveal Email/Phone |
7 | Head Corporate Operations | Reveal Email/Phone |
8 | Head Facility (Belgium) | Reveal Email/Phone |
9 | Head global R&D Operations | Reveal Email/Phone |
10 | VP Quality (IL) & Global Regulatory Affairs | Reveal Email/Phone |
Orgenesis Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.3M | 2 | -60% | N/A | N/A |
#2 | $2.9M | 38 | -31% | $17.5M | N/A |
#3 | $2.9M | 38 | -33% | $10.5M | N/A |
#4 | $19.8M | 128 | 0% | $69.4M | N/A |
#5 | $9.6M | 62 | -15% | N/A | N/A |
#6 | $1.4M | 9 | 0% | N/A | N/A |
#7 | $2.5M | 16 | 0% | N/A | N/A |
#8 | $7.4M | 48 | 0% | N/A | N/A |
#9 | $0.2M | 1 | -83% | N/A | N/A |
#10 | $1.7M | 11 | 22% | N/A | N/A |
What Is Orgenesis?
Orgenesis is a global biotech company working to unlock the full potential of cell and gene therapies (CGTs) in an affordable and accessible format at the point of care. The Orgenesis POCare Platform is comprised of three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network. Orgenesis identifies promising new therapies and leverages its POCare Platform to provide a rapid, globally harmonized pathway for these therapies to reach and treat large numbers of patients at lowered costs through efficient, scalable, and decentralized production. The Network brings together patients, doctors, industry partners, research institutes and hospitals worldwide to achieve harmonized, regulated clinical development and production of the therapies. Learn more about the work Orgenesis is doing at www.orgenesis.com.
keywords:Biotech, Cell & Gene Therapy
$29.3M
Total Funding
83
Number of Employees
$15.2M
Revenue (est)
19%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Orgenesis News
Orgenesis, Inc. (NASDAQ:ORGS) Q4 2021 Earnings Conference Call March 30, 2022 ET. Company Participants. David Waldman Investor Relations.
Orgenesis is a global biotech company working to unlock the full potential of cell and gene therapies (CGTs) in an affordable and accessible...
Proactive news headlines including Orgenesis, Numinus Wellness, ElectraMeccanica Vehicles, Red Pine Exploration and Equity Metals.
Orgenesis Inc. (NASDAQ: ORGS), a Germantown, MD, US-based biotech company, completed acquiring the assets of Tamir Biotechnology, Inc., including ranpirnase, its broad spectrum anti-viral platform. The acquisition included total stock and cash consideration of approximately USD 21m, based on th ...
Orgenesis (OTC:ORGS) said it raised $3 million after selling stock to institutional investor Kodiak Capital Group. Orgenesis is developing a novel regenerative medicine technology that converts a diabetic patient’s liver cells into functioning insulin-producing cells. The White Plains, NY-base ...
Other Companies in Germantown
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $14.9M | 83 | 11% | N/A |
#2 | $12.3M | 85 | 9% | N/A |
#3 | $19.7M | 87 | -7% | N/A |
#4 | $25.2M | 87 | 5% | N/A |
#5 | $21.6M | 88 | 7% | N/A |